help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stacher, G.
Right arrow Articles by Weber, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stacher, G.
Right arrow Articles by Weber, U.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 7 2357-2362
Copyright © 1999 by The Endocrine Society


Original Studies

Cisapride Versus Placebo for 8 Weeks on Glycemic Control and Gastric Emptying in Insulin-Dependent Diabetes: A Double Blind Cross-Over Trial1

Georg Stacher, Guntram Schernthaner, Mario Francesconi, Hans-Peter Kopp, Helmar Bergmann, Giselheid Stacher-Janotta and Ute Weber

Psychophysiology Unit, Department of Surgery (G.St., G.St.-J., U.W.), and Departments of Biomedical Engineering and Physics (H.B.) and Nuclear Medicine (H.B.), University of Vienna, A-1090 Vienna; Department of Medicine I, Krankenanstalt Rudolfstiftung (G.Sc., H.-P.K.) A-1030 Vienna; Ludwig Boltzmann Institute of Nuclear Medicine (H.B.); A-1090 Vienna; and Rehabilitationszentrum der PVA (M.F.), A-2356 Alland, Austria

Address all correspondence and requests for reprints to: Prof. Georg Stacher, M.D., Psychophysiologisches Laboratorium, Waehringer Guertel 18–20, A-1090 Wien, Austria. E-mail: georg.stacher{at}akh-wien.ac.at

In insulin-dependent diabetes mellitus, slow gastric emptying may make absorption unpredictable and foster glycemic instability. Cisapride accelerates emptying, but controlled long term studies are scarce, and effects on glycemic control unknown. We investigated, in patients with insulin-dependent diabetes mellitus and unstable glycemia, the effects of 10 mg cisapride 4 times daily for 8 weeks vs. placebo on glycemic control and gastric emptying under random, cross-over, double blind conditions. In 14 patients with delayed and 9 with nondelayed emptying, blood glucose variability over 2 8-week treatment periods separated by a 4-week wash-out and gastric emptying of a semisolid 1168-kJ meal immediately after the treatment periods were assessed. Cisapride did not affect glycemic control [SD of within-patient mean blood glucose, 4.2 mmol/L ± 0.1 (±SEM) vs. 4.0 ± 0.1 mmol/L after placebo; hemoglobin A1c, 8.3 ± 0.2% vs. 8.5 ± 0.2%]. Emptying was faster after cisapride than after placebo in 8 of 14 patients with delayed vs. 7 of 9 with nondelayed emptying (P = NS) and in 11 of 15 without vs. 4 of 8 with cardiovascular autonomic neuropathy (P = NS). Autonomic neuropathy prevailed in 7 of 14 patients with delayed and 1 of 9 with nondelayed emptying. Blood glucose immediately before and during assessment of emptying was unrelated to the emptying rate, whereas blood glucose increases over fasting levels were greater with faster emptying (P < 0.002). In conclusion, cisapride’s effects were not different from those of placebo on glycemic control and gastric emptying, it did not differently affect patients with delayed vs. nondelayed emptying, and it slightly accelerated emptying (P = NS) in patients without, but not in those with, cardiovascular autonomic neuropathy. Blood glucose levels before and during assessment of emptying did not affect emptying, but the glucose rise over fasting levels was greater with faster emptying.




This article has been cited by other articles:


Home page
DiabetesHome page
J. J. Meier, G. Kemmeries, J. J. Holst, and M. A. Nauck
Erythromycin Antagonizes the Deceleration of Gastric Emptying by Glucagon-Like Peptide 1 and Unmasks Its Insulinotropic Effect in Healthy Subjects
Diabetes, July 1, 2005; 54(7): 2212 - 2218.
[Abstract] [Full Text] [PDF]


Home page
GutHome page
N J Talley, M Verlinden, D J Geenen, R B Hogan, D Riff, R W McCallum, and R J Mack
Effects of a motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: a randomised, double blind, placebo controlled trial
Gut, September 1, 2001; 49(3): 395 - 401.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
C. K. Rayner, M. Samsom, K. L. Jones, and M. Horowitz
Relationships of Upper Gastrointestinal Motor and Sensory Function With Glycemic Control
Diabetes Care, February 1, 2001; 24(2): 371 - 381.
[Abstract] [Full Text]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society